Concinnity

Concinnity, a spinout from the University of Edinburgh, is transforming gene therapy safety by designing novel control mechanisms using AI and synthetic biology. Its RNA-based systems enable precise control of gene therapies, even after dosing, allowing for response and reduction of side effects. This technology is considered a significant advancement in the field.

Buy Funded Startups lists

Funding Round: Seed

Funding Amount: £3M

Date: 16-Dec-2024

Investors: Eos Advisory, Scottish Enterprise, Old College Capital (OCC), Maven Capital Partners

Markets: Biotech, Gene Therapy, AI, Synthetic Biology

HQ: Edinburgh, Scotland, United Kingdom

Founded: 2021

Website: https://www.concinnitygenetics.com/

LinkedIn: https://uk.linkedin.com/company/concinnity-genetics

Twitter:

Instagram: